Activin A, B and AB decrease progesterone production by down-regulating StAR in human granulosa cells

Molecular and Cellular Endocrinology

Volumn 412, Issue , 2015, Pages 290-301

  Chang, Hsun Ming ^b   Cheng, Jung Chien ^b   Huang, He Feng ^a,c   Shi, Feng Tao ^a,c   Leung, Peter C K ^a,b  

^a School of Medicine   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Activin A; Activin AB; Activin B; Human granulosa cells; Progesterone; StAR

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXY 1 METHYLTETRALIN; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ACTIVIN; ACTIVIN A; ACTIVIN AB; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOPID; PROTEIN KINASE B; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; ACTIVIN RECEPTOR 1; ACVR1B PROTEIN, HUMAN; PHOSPHOPROTEIN; PROGESTERONE; PROTEIN SERINE THREONINE KINASE; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN, HUMAN; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GRANULOSA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA SYNTHESIS; BIOSYNTHESIS; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ACTIVIN RECEPTORS, TYPE I; ACTIVINS; CELLS, CULTURED; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; GRANULOSA CELLS; HUMANS; PHOSPHOPROTEINS; PROGESTERONE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN;

EID: 84939469540     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.05.016     Document Type: Article

References (41)

1. Alak B.M., Coskun S., Friedman C.I., Kennard E.A., Kim M.H., Seifer D.B. Activin A stimulates meiotic maturation of human oocytes and modulates granulosa cell steroidogenesis in vitro. Fertil. Steril 1998, 70:1126-1130.
2. Bernard D.J., Lee K.B., Santos M.M. Activin B can signal through both ALK4 and ALK7 in gonadotrope cells. Reprod. Biol. Endocrinol 2006, 4:52.
3. Brown K.A., Pietenpol J.A., Moses H.L. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J. Cell. Biochem 2007, 101:9-33.
4. Chang H.M., Cheng J.C., Klausen C., Taylor E.L., Leung P.C. Effects of recombinant activins on steroidogenesis in human granulosa-lutein cells. J. Clin. Endocrinol. Metab 2014, 99:E1922-E1932.
5. Chang H.M., Cheng J.C., Taylor E., Leung P.C. Oocyte-derived BMP15 but not GDF9 down-regulates connexin43 expression and decreases gap junction intercellular communication activity in immortalized human granulosa cells. Mol. Hum. Reprod 2014, 20:373-383.
6. Chang H.M., Cheng J.C., Fang L., Qiu X., Klausen C., Taylor E.L., et al. Recombinant BMP4 and BMP7 down-regulate pentraxin 3 in human granulosa cells. J. Clin. Endocrinol. Metab 2015, 100:E365-E374. jc20142496.
7. Chang H.M., Cheng J.C., Klausen C., Leung P.C. Recombinant BMP4 and BMP7 increase activin A production by up-regulating inhibin betaA subunit and furin expression in human granulosa-lutein cells. J. Clin. Endocrinol. Metab 2015, 100:E375-E386. jc20143026.
8. Chang H.M., Fang L., Cheng J.C., Klausen C., Sun Y.P., Leung P.C. Growth differentiation factor 8 down-regulates pentraxin 3 in human granulosa cells. Mol. Cell. Endocrinol 2015, 404:82-90.
9. de Guise C., Lacerte A., Rafiei S., Reynaud R., Roy M., Brue T., et al. Activin inhibits the human Pit-1 gene promoter through the p38 kinase pathway in a Smad-independent manner. Endocrinology 2006, 147:4351-4362.
10. Dennler S., Huet S., Gauthier J.M. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 1999, 18:1643-1648.
11. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
12. Do T.V., Kubba L.A., Antenos M., Rademaker A.W., Sturgis C.D., Woodruff T.K. The role of activin A and Akt/GSK signaling in ovarian tumor biology. Endocrinology 2008, 149:3809-3816.
13. Drummond A.E., Le M.T., Ethier J.F., Dyson M., Findlay J.K. Expression and localization of activin receptors, Smads, and beta glycan to the postnatal rat ovary. Endocrinology 2002, 143:1423-1433.
14. Dupont J., McNeilly J., Vaiman A., Canepa S., Combarnous Y., Taragnat C. Activin signaling pathways in ovine pituitary and LbetaT2 gonadotrope cells. Biol. Reprod 2003, 68:1877-1887.
15. Evans L.W., Muttukrishna S., Knight P.G., Groome N.P. Development, validation and application of a two-site enzyme-linked immunosorbent assay for activin-AB. J. Endocrinol 1997, 153:221-230.
16. Fang L., Chang H.M., Cheng J.C., Leung P.C., Sun Y.P. TGF-beta1 downregulates StAR expression and decreases progesterone production through Smad3 and ERK1/2 signaling pathways in human granulosa cells. J. Clin. Endocrinol. Metab 2014, 99:E2234-E2243.
17. Ginther O.J., Beg M.A., Bergfelt D.R., Kot K. Activin A, estradiol, and free insulin-like growth factor I in follicular fluid preceding the experimental assumption of follicle dominance in cattle. Biol. Reprod 2002, 67:14-19.
18. Glister C., Groome N.P., Knight P.G. Bovine follicle development is associated with divergent changes in activin-A, inhibin-A and follistatin and the relative abundance of different follistatin isoforms in follicular fluid. J. Endocrinol 2006, 188:215-225.
19. Greenwald J., Groppe J., Gray P., Wiater E., Kwiatkowski W., Vale W., et al. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell 2003, 11:605-617.
20. Gu Z., Nomura M., Simpson B.B., Lei H., Feijen A., van den Eijnden-van Raaij J., et al. The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse. Genes Dev 1998, 12:844-857.
21. Hillier S.G., Miro F. Inhibin, activin, and follistatin. Potential roles in ovarian physiology. Ann. N. Y. Acad. Sci 1993, 687:29-38.
22. Inman G.J., Nicolas F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol 2002, 62:65-74.
23. Knight P.G., Glister C. Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reproduction 2001, 121:503-512.
24. Knight P.G., Satchell L., Glister C. Intra-ovarian roles of activins and inhibins. Mol. Cell. Endocrinol 2012, 359:53-65.
25. Li Y., Klausen C., Cheng J.C., Zhu H., Leung P.C. Activin A, B, and AB increase human trophoblast cell invasion by up-regulating N-cadherin. J. Clin. Endocrinol. Metab 2014, 99:E2216-E2225.
26. Lie B.L., Leung E., Leung P.C., Auersperg N. Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen. Mol. Cell. Endocrinol 1996, 120:169-176.
27. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem 1998, 67:753-791.
28. Massague J., Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 2000, 19:1745-1754.
29. Matzuk M.M., Kumar T.R., Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 1995, 374:356-360.
30. Miro F., Smyth C.D., Hillier S.G. Development-related effects of recombinant activin on steroid synthesis in rat granulosa cells. Endocrinology 1991, 129:3388-3394.
31. Muttukrishna S., Fowler P.A., George L., Groome N.P., Knight P.G. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J. Clin. Endocrinol. Metab 1996, 81:3328-3334.
32. Nishimori K., Matzuk M.M. Transgenic mice in the analysis of reproductive development and function. Rev. Reprod 1996, 1:203-212.
33. Piek E., Ju W.J., Heyer J., Escalante-Alcalde D., Stewart C.L., Weinstein M., et al. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J. Biol. Chem 2001, 276:19945-19953.
34. Rabinovici J., Goldsmith P.C., Roberts V.J., Vaughan J., Vale W., Jaffe R.B. Localization and secretion of inhibin/activin subunits in the human and subhuman primate fetal gonads. J. Clin. Endocrinol. Metab 1991, 73:1141-1149.
35. Roberts V.J., Barth S., el-Roeiy A., Yen S.S. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J. Clin. Endocrinol. Metab 1993, 77:1402-1410.
36. Shi Y., Wang Y.F., Jayaraman L., Yang H., Massague J., Pavletich N.P. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell 1998, 94:585-594.
37. Sidis Y., Fujiwara T., Leykin L., Isaacson K., Toth T., Schneyer A.L. Characterization of inhibin/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: evidence for activin's paracrine signaling from granulosa cells to oocytes. Biol. Reprod 1998, 59:807-812.
38. Smitz J., Cortvrindt R., Hu Y., Vanderstichele H. Effects of recombinant activin A on in vitro culture of mouse preantral follicles. Mol. Reprod. Dev 1998, 50:294-304.
39. Tsuchida K., Nakatani M., Yamakawa N., Hashimoto O., Hasegawa Y., Sugino H. Activin isoforms signal through type I receptor serine/threonine kinase ALK7. Mol. Cell. Endocrinol 2004, 220:59-65.
40. Young J.M., Henderson S., Souza C., Ludlow H., Groome N., McNeilly A.S. Activin B is produced early in antral follicular development and suppresses thecal androgen production. Reproduction 2012, 143:637-650.
41. Zhang L., Deng M., Parthasarathy R., Wang L., Mongan M., Molkentin J.D., et al. MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol. Cell. Biol 2005, 25:60-65.